Commodity Printing & Stationery company DOMS Industries announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue from Operations for Q4’FY25 grew by 26.0% to Rs 508.7 crore as compared to Rs 403.7 crore in Q4FY24. EBITDA for Q4FY25 grew by 16.2% to Rs 88.3 crore as compared to Rs 75.9 crore in Q4’FY24. EBIDTA margin for Q4FY25 stood at 17.3% as compared to 18.8% in Q4FY24. PAT for Q4FY25 grew by 9.3% to Rs 51.3 crore as compared to Rs 46.9 crore in Q4’FY24. PAT margin for Q4FY25 stood at 10.1% as compared to 11.6% in Q4’FY24. FY25 Financial Highlights: Revenue from Operations for FY25 grew by 24.4% to Rs 1,912.6 crore as compared to Rs 1,537.1 crore in FY24. EBITDA for FY25 grew by 27.8% to Rs 348.4 crore as compared to Rs 272.7 crore in FY24. EBIDTA margin for FY25 rose to 18.2% as compared to 17.7% in FY24. PAT for FY25 grew by 33.7% to Rs 213.5 crore as compared to Rs 159.7 crore in FY24. PAT margin for FY25 rose to 11.2% as compared to 10.4% in FY24. Commenting on the results and performance, Santosh Raveshia, Managing Director, DOMS Industries said: “We are pleased to report a resilient performance in FY 2025, achieved amidst a backdrop of macro economic uncertainty and evolving market dynamics. Our continued focus on execution and operational discipline has helped us deliver an encouraging revenue growth of nearly 25%. This growth was supported by steady performance across our core categories, the launch of new products, and the smooth integration of Uniclan. In recognition of this performance, the Board has recommended a dividend of Rs 3.15 per share (31.5%), subject to shareholder approval. As we remain committed to our long-term vision, we continue to invest in expanding our product portfolio, scaling our capacities, and strengthening our market presence. The Board-approved acquisition of a 51% stake in Super Treads Private Limited - a Siliguri-based paper stationery company - aligns well with this strategy. It will enhance our production capabilities in the paper stationery segment and improve our ability to serve the growing demand in East India. Looking ahead, while we remain watchful of external uncertainties, we are optimistic about a gradual recovery in domestic demand. In FY 2026, we aim to maintain our double-digit growth trajectory, underpinned by planned capacity enhancements in scholastic stationery, office supplies, and paper stationery. With our 44-acre land parcel construction underway in full swing, with anticipated possession of first building by Q3FY26, and beginning of commercial production slated for Q4FY26, we're poised to sustain our growth momentum leveraging the expanded capacities. Building on a focused growth strategy and strong business fundamentals, we will continue to drive value creation through prudent, profitable initiatives that position us well for the future.” Result PDF
Commodity Printing & Stationery company DOMS Industries announced Q3FY25 results Revenue from Operations for Q3FY25 grew by 34.9% to Rs 501.1 crore as compared to Rs 371.6 crore in Q3FY24. EBITDA for Q3FY25 grew by 26.7% to Rs 87.9 crore as compared to Rs 69.3 crore in Q3FY24. EBIDTA margin for Q3FY25 stood at 17.5% as compared to 18.7% in Q3FY24. PAT for Q3FY25 grew by 39.8% to Rs 54.3 crore as compared to Rs 38.8 crore in Q3FY24. PAT margin for Q3FY25 rose to 10.8% as compared to 10.4% in Q3FY24. Santosh Raveshia, Managing Director, DOMS Industries, said: “Despite the tepid market conditions and festive season in India as well as globally, we continued on our consistent growth trajectory during Q3FY25. Our strategic initiatives have played a pivotal role in fuelling this growth. The successful acquisition of Uniclan Healthcare, which lead our entry into Baby Hygiene products, coupled with our timely expansion of capacities across various product categories, have all contributed positively to our quarterly performance. Company's manufacturing cost structure broadly remained stable in Q3FY25, with input prices holding steady, resulting in consistent gross margins on a sequential basis. Consolidated EBITDA for the quarter grew 26.7% YoY and 2.2% sequentially. However, there was a slight margin compression of approximately 120 bps QoQ which was primarily driven by increased employee expenses, stemming from additional hiring to support production capacity expansion and impact of ESOP grants to reward employees. Furthermore, we witnessed an increase in selling and distribution expenses primarily on account of consolidation of Uniclan Healthcare. As a result of these factors, Company's consolidated EBITDA margin stood at 17.5%, as on expected lines, but higher than our targeted range of 16-17%. Going forward, we remain cautiously optimistic in the near term, on improvement in demand conditions with tailwinds from the upcoming back to school season, growing emphasis on education and increased Governments’ spending in this sector, contributing to the growth momentum. Our strategic priorities remain unchanged with focus on delivering consistent and profitable volume growth through expanding our production capacities, investing in our brands and strengthening our supply chain, positioning ourselves for sustainable long-term growth. Lastly, I would like to appreciate the unwavering dedication and relentless efforts of our entire team and channel partners, who have worked tirelessly to drive this growth and excellence. Further, we extend our heartfelt gratitude to our valued consumers for embracing our products. Their unwavering support fuels our passion and inspires our team to innovate, design, and deliver high-quality products to meet the evolving needs of our consumers.” Result PDF